Reports: ZORA Program (Slovenia): Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]]. | '''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]]. | ||
'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; The ratio between the number of newly detected precancerous and cancerous changes per year. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more]. | '''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines ([[availableVariable::screening]]); The number of new patients in a given year; (RMV [[availableVariable::cancer incidence|incidence]] rate); [[availableVariable::number of deaths|Mortality]] due to RMV; [[availableVariable::causes of death]]; The ratio between the number of newly detected precancerous and cancerous changes per [[availableVariable::year]]. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more]. | ||
'''Data level:''' [[dataLevel::national level]]. | '''Data level:''' [[dataLevel::national level]]. | ||
Revision as of 12:20, 17 June 2024
Go back to Slovenia page
Primary purpose: To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.
Sponsor, manager or home institution: Ljubljana Oncology Institute; ZORA Program.
Type of information: The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; causes of death; The ratio between the number of newly detected precancerous and cancerous changes per year. Click here to learn more.
Data level: national level.
Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.
Access to information: Click here to access.